Nicole F Maranchick

Nicole F Maranchick,

Pharmacist

Department: Pharmacotherapy & Translational Research
Business Phone: (352) 273-6803
Business Email: n.maranchick@ufl.edu

Publications

2024
Association of piperacillin and vancomycin exposure on acute kidney injury during combination therapy.
JAC-antimicrobial resistance. 6(1) [DOI] 10.1093/jacamr/dlad157. [PMID] 38259903.
2024
Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics
Expert Review of Clinical Pharmacology. 17(7):537-547 [DOI] 10.1080/17512433.2024.2317954. [PMID] 38339997.
2024
Role of therapeutic drug monitoring in the treatment of multi-drug resistant tuberculosis
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 36 [DOI] 10.1016/j.jctube.2024.100444. [PMID] 38708036.
2023
A Randomized Clinical Trial of Bayesian-Guided Beta-Lactam Infusion Strategy and Associated Bacterial Resistance and Clinical Outcomes in Patients With Severe Pneumonia
Therapeutic Drug Monitoring. 46(1):95-101 [DOI] 10.1097/ftd.0000000000001144. [PMID] 38018847.
2023
Adequacy of WHO weight-band dosing and fixed-dose combinations for the treatment of TB in children.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 27(5):401-407 [DOI] 10.5588/ijtld.22.0591. [PMID] 37143230.
2023
Beta-lactam target attainment and associated outcomes in patients with bloodstream infections
International Journal of Antimicrobial Agents. 61(3) [DOI] 10.1016/j.ijantimicag.2023.106727. [PMID] 36646230.
2023
Cefepime Daily Exposure and the Associated Impact on the Change in Sequential Organ Failure Assessment Scores and Vasopressors Requirement in Critically Ill Patients Using Repeated-Measures Mixed-Effect Modeling
Critical Care Explorations. 5(11) [DOI] 10.1097/cce.0000000000000993. [PMID] 38304706.
2023
Effect of HIV infection on plasma exposure to first-line TB drugs and target attainment in children
The International Journal of Tuberculosis and Lung Disease. 27(12):931-937 [DOI] 10.5588/ijtld.23.0184. [PMID] 38042977.
2023
Impact of Beta-Lactam Target Attainment on Resistance Development in Patients with Gram-Negative Infections
Antibiotics. 12(12) [DOI] 10.3390/antibiotics12121696. [PMID] 38136730.
2023
Making the case for precision dosing: visualizing the variability of cefepime exposures in critically ill adults.
The Journal of antimicrobial chemotherapy. 78(9):2170-2174 [DOI] 10.1093/jac/dkad211. [PMID] 37449472.
2023
Pharmacokinetics and pharmacodynamics of adult dolutegravir tablets in treatment-experienced children with HIV weighing at least 20 kg
AIDS. Publish Ahead of Print(9):1409-1417 [DOI] 10.1097/qad.0000000000003576. [PMID] 37070558.
2023
The effect of anti-tuberculosis drug pharmacokinetics on QTc prolongation
International Journal of Antimicrobial Agents. 62(4) [DOI] 10.1016/j.ijantimicag.2023.106939. [PMID] 37517627.
2022
Cerebrospinal fluid concentrations of fluoroquinolones and carbapenems in tuberculosis meningitis.
Frontiers in pharmacology. 13 [DOI] 10.3389/fphar.2022.1048653. [PMID] 36578553.
2022
Meropenem Population Pharmacokinetics and Simulations in Plasma, Cerebrospinal Fluid, and Brain Tissue.
Antimicrobial agents and chemotherapy. 66(8) [DOI] 10.1128/aac.00438-22. [PMID] 35862739.
2022
Use of therapeutic drug monitoring to characterize cefepime-related neurotoxicity.
Pharmacotherapy. 43(1):6-14 [DOI] 10.1002/phar.2744. [PMID] 36401796.
2022
Using Machine Learning To Define the Impact of Beta-Lactam Early and Cumulative Target Attainment on Outcomes in Intensive Care Unit Patients with Hospital-Acquired and Ventilator-Associated Pneumonia.
Antimicrobial agents and chemotherapy. 66(7) [DOI] 10.1128/aac.00563-22. [PMID] 35699444.

Contact Details

Phones:
Business:
(352) 273-6803
Emails:
Addresses:
Business Mailing:
PO Box 100486
GAINESVILLE FL 32610
Business Street:
1600 SW ARCHER RD
GAINESVILLE FL 32610